Seasonal influenza is a vaccine-preventable disease that each year infects approximately ten to thirty per cent of Europe's population, and causes hundreds of thousands of hospitalisations across Europe. Older people, younger children and those with chronic conditions suffer the most, but everyone is at risk of developing serious complications—which include pneumonia, myocarditis and encephalitis—that may result in death.
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017
2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.
- Weekly influenza update
- Influenza Virus Characterisations Reports, summary Europe
- Disease data from ECDC Surveillance Atlas
- Influenza season summaries
- Annual epidemiological reports
- National, regional and global influenza surveillance reports
- Facts about influenza surveillance
- ECDC publications and peer-reviewed articles
Microbiology and laboratory reports; External quality assessments, Influenza virus characterisations.
ECDC brings together health communication research and best practices, and develops practical resources with the aim to assist public health authorities in Member States in their health promotion initiatives.
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for eight influenza seasons (2007–2008 to 2014–2015)
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Check interim results from five European studies.Go to the article
30% of the burden of communicable diseases in Europe is due to influenza
New study in Eurosurveillance, published April 2018, on the impact of infectious diseases on population in the European Union and European Economic Area countries.Go to the article
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza?
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Published in the Science, 36 (4), 25 Jan 2018.Go to the article
Other types of influenza
2009 influenza A (H1N1) pandemic
The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
Avian influenza is an infectious viral disease in birds, including domestic poultry. Avian influenza is mainly found in birds, but under certain circumstances infections can also occur in humans even though the risk is generally very low.
Swine influenza is a respiratory disease of pigs caused by type A influenza viruses that regularly cause outbreaks of influenza in pigs. Influenza viruses that commonly circulate in swine are called “swine influenza viruses” or “swine flu viruses.” Like human influenza viruses, there are different subtypes and strains of swine influenza viruses.